New hope for devastating mitochondrial disease
Disease control
Recruiting now
This study is testing whether an oral medicine called TTI-0102 can help control symptoms and improve daily function in people with MELAS, a rare and serious genetic disorder that affects energy production in the body. About 12 participants, aged 16-60 with moderate disease, will …
Phase: PHASE2 • Sponsor: Thiogenesis Therapeutics, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC